Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Israeli drugmaker reports widening quarterly loss but lifts outlook
Four plaintiffs aim to persuade others to sign on to framework
First federal lawsuit to proceed after local governments call offer ‘inadequate’
Drugmaker’s earnings better than expected but investors nervous about potential liabilities
Pharmaceuticals company settles ahead of trial over state’s drugs crisis
Schultz likens claims against drugmakers to blaming drunk driving on makers of alcoholic drinks
World’s biggest generic drugmaker cautions that sales and profits will be lower
Ruling allows launch of rival to Mylan’s allergy injector
Teva is now a value play even if the boss is not paying attention
Israeli drugmaker’s shares drop as competition to top drug Copaxone bites
Pfizer among those risking backlash with new year increases on many medicines
Problem is that some things are cheap for a reason
Backlash feared from customers and politicians as Israeli drugmaker rejigs ailing operations
CEO Kåre Schultz says cuts will be made carefully and ‘not in a harvest way’
Shares in health insurance group rise on takeover reports sending valuation to $60bn
